Drug intelligence / Profile preview

salicylic acid + turmeric

Development stage: Unknown
Lead developer: Nuvothera
Modality: Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical, Oral

Overview

A combination of salicylic acid and turmeric (containing curcumin) that leverages the complementary properties of both compounds. Salicylic acid provides keratolytic and anti-inflammatory effects, while turmeric contributes anti-inflammatory, antioxidant, and potential anti-cancer properties. This combination has been studied for dermatological conditions like psoriasis and for enhancing the therapeutic effects while reducing side effects when used systemically.

Brand names: ProsoriaGZE KOJIC ACID TURMERIC CLEANSING PADS
Other names: salicylic acid and turmeric gelturmeric/salicylic acid gel

Targets

IKK complexCOXTNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on salicylic acid + turmeric.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on salicylic acid + turmeric.

Explore the full profile